THOMSON ACQUIRES UNLEASHED INFORMATICS LTD

Addition of Bioinformatics Content Offering Will Enhance Thomson Scientific Offering for Pharmaceutical Community

Stamford, CONN, USA - March 20, 2007 — The Thomson Corporation (NYSE: TOC; TSX: TOC) today announced that its Scientific business unit has acquired privately-held Unleashed Informatics Ltd, a life sciences data management company. Unleashed Informatics is the market leader in bioinformatics data and owns the largest repository of value-added bioinformatics records — a highly significant area for target-based drug discovery. Its management team and employees will become part of Thomson Scientific. Financial terms of the transaction were not disclosed.

Unleashed Informatics is highly regarded for its subscription-based stable of public and proprietary biological databases, including:
  • BIND (Biomolecular Interaction Network Database) containing 200,000 biomolecular interactions
  • SMID (Small Molecule Interaction Database) containing over 23 million experimentally observed small molecule interactions
  • BOND (Biomolecular Object Network Database) data warehouse that combines access to BIND and SMID data with publicly-accessible databases, plus similarity search algorithms
Over 11,000 researchers in more than 3,000 organizations worldwide rely on content, tools and analytics from Unleashed Informatics to advance their life sciences investigations. Thomson will continue to make complimentary versions of BOND and BIND available to Unleashed Open Access registrants.

"The volume and variety of biological data being generated in laboratories worldwide represents a profound scientific challenge," said Jon Brett Harris, executive vice president of Pharmaceutical and Chemical Markets at Thomson Scientific. "The integration of Unleashed Informatics with Thomson Scientific data, particularly the 8.5 million genetic sequences in our GENESEQ database, will enable us to deliver greater value for research scientists working in biology-driven drug discovery."

"Thomson has a compelling plan and capacity to satisfy life science information needs from primary research through to product delivery," said Eric Andrade, president and CEO of Unleashed Informatics. "This acquisition will enable the Unleashed mission to assemble, integrate, and deliver real time access to man’s biomolecular knowledge."
About The Thomson Corporation
The Thomson Corporation (www.thomson.com) is a global leader in providing essential electronic workflow solutions to business and professional customers. With operational headquarters in Stamford, Conn., Thomson provides value-added information, software tools and applications to professionals in the fields of law, tax, accounting, financial services, scientific research and healthcare. The Corporation's common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Thomson Scientific is a business of The Thomson Corporation. Its information solutions assist professionals at every stage of research and development—from discovery to analysis to product development and distribution. Thomson Scientific information solutions can be found at scientific.thomson.com.

About Unleashed Informatics Limited
Unleashed Informatics Ltd. provides innovative, high-speed, integrated hardware and software products designed to harness the power of increasingly complex scientific data. Unleashed Informatics products are targeted to the general life sciences market, including biotechnology and pharmaceutical firms, with a focus on bioinformatics, genomics, proteomics, and cheminformatics applications.

Visit the company website at www.unleashedinformatics.com.

For more information contact:
Allison Hagan
Director, PR & Communications
Thomson Scientific
Tel: +1 215-823-1881
E-mail: allison.hagan@thomson.com


Media Contact

Allison Hagan
+ 1-215-823-1881